Current Perspectives in Dementia with Lewy Bodies

• O‘Brien J , McKeithI, AmesD, ChiuE: Preface. In:Dementia with Lewy Bodies (1st Edition). Taylor & Francis, xiii (2006).
   Google Scholar
• Okazaki H , LipkinLE, AronsonSM: Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion.J. Neuropathol. Exp. Neurol.20, 237–244(1961).
   PubMed Web of Science ®Google Scholar
• Cummings JL : Dementia with lewy bodies: molecular pathogenesis and implications for classification.J. Geriatr. Psychiatry Neurol.17(3), 112–119(2004).
   PubMed Web of Science ®Google Scholar
• Galvin JE , LeeVM, TrojanowskiJQ: Synucleinopathies: clinical and pathological implications.Arch. Neurol.58(2), 186–190(2001).
   PubMedGoogle Scholar
• McKeith IG , GalaskoD, KosakaKet al.: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.Neurology47(5), 1113–1124(1996).
   PubMed Web of Science ®Google Scholar
• McKeith IG , DicksonDW, LoweJet al.: Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium.Neurology65(12), 1863–1872(2005).
   PubMed Web of Science ®Google Scholar
• McKeith I , MintzerJ, AarslandDet al.: Dementia with Lewy bodies.Lancet Neurol.3(1), 19–28(2004).
   PubMed Web of Science ®Google Scholar
• Perry RH , IrvingD, BlessedG, FairbairnA, PerryEK: Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.J. Neurol. Sci.95(2), 119–139(1990).
   PubMed Web of Science ®Google Scholar
• Yamada T , KadekaruH, MatsumotoSet al.: Prevalence of dementia in the older Japanese–Brazilian population.Psychiatry Clin. Neurosci.56(1), 71–75(2002).
   PubMed Web of Science ®Google Scholar
• Londos E , PassantU, GustafsonL, BrunA: Neuropathological correlates to clinically defined dementia with Lewy bodies.Int. J. Geriatr. Psychiatry16(7), 667–679(2001).
   PubMed Web of Science ®Google Scholar
• Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet357(9251), 169–175(2001).
   PubMed Web of Science ®Google Scholar
• McKeith IG , GalaskoD, WilcockGK, ByrneEJ: Lewy body dementia – diagnosis and treatment.Br. J. Psychiatry167(6), 709–717(1995).
   PubMedGoogle Scholar
• Stevens T , LivingstonG, KitchenG, ManelaM, WalkerZ, KatonaC: Islington study of dementia subtypes in the community.Br. J. Psychiatry180, 270–276(2002).
   PubMed Web of Science ®Google Scholar
• Rahkonen T , Eloniemi-SulkavaU, RissanenS, VatanenA, ViramoP, SulkavaR: Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older.J. Neurol. Neurosurg. Psychiatr.74(6), 720–724(2003).
   PubMed Web of Science ®Google Scholar
• Haan MN , MungasDM, GonzalezHM, OrtizTA, AcharyaA, JagustWJ: Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.J. Am. Geriatr. Soc.51(2), 169–177(2003).
   PubMed Web of Science ®Google Scholar
• Herrera E Jr, Caramelli P, Silveira AS, Nitrini R: Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis. Assoc. Disord.16(2), 103–108(2002).
   PubMed Web of Science ®Google Scholar
• de Silva HA , GunatilakeSB, SmithAD: Prevalence of dementia in a semi-urban population in Sri Lanka: report from a regional survey.Int. J. Geriatr. Psychiatry18(8), 711–715(2003).
   PubMed Web of Science ®Google Scholar
• Yamada T , HattoriH, MiuraA, TanabeM, YamoriY: Prevalence of Alzheimer‘s disease, vascular dementia and dementia with Lewy bodies in a Japanese population.Psychiatry Clin. Neurosci.55(1), 21–25(2001).
   PubMed Web of Science ®Google Scholar
• Zaccai J , McCrackenC, BrayneC: A systematic review of prevalence and incidence studies of dementia with Lewy bodies.Age Ageing34(6), 561–566(2005).
   PubMed Web of Science ®Google Scholar
• Parkkinen L , SoininenH, LaaksoM, AlafuzoffI: Alpha-synuclein pathology is highly dependent on the case selection.Neuropathol. Appl. Neurobiol.27(4), 314–325(2001).
   PubMed Web of Science ®Google Scholar
• Parkkinen L , KauppinenT, PirttilaT, AutereJM, AlafuzoffI: Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.Ann. Neurol.57(1), 82–91(2005).
   PubMed Web of Science ®Google Scholar
• Parkkinen L , PirttilaT, TervahautaM, AlafuzoffI: Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.Neuropathology25(4), 304–314(2005).
   PubMed Web of Science ®Google Scholar
• Olanow CW , PerlDP, DeMartinoGN, McNaughtKS: Lewy-body formation is an aggresome-related process: a hypothesis.Lancet Neurol.3(8), 496–503(2004).
   PubMed Web of Science ®Google Scholar
• Saito Y , RuberuNN, SawabeMet al.: Lewy body-related alpha-synucleinopathy in aging.J. Neuropathol. Exp. Neurol.63(7), 742–749(2004).
   PubMed Web of Science ®Google Scholar
• Yamamoto R , IsekiE, MaruiWet al.: Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies.Neuropathology25(3), 188–194(2005).
   PubMed Web of Science ®Google Scholar
• Aarsland D , PerryR, BrownA, LarsenJP, BallardC: Neuropathology of dementia in Parkinson‘s disease: a prospective, community-based study.Ann. Neurol.58(5), 773–776(2005).
   PubMed Web of Science ®Google Scholar
• Litvan I , BhatiaKP, BurnDJet al.: Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.Mov. Disord.18(5), 467–486(2003).
   PubMed Web of Science ®Google Scholar
• McKeith IG , BallardCG, PerryRHet al.: Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.Neurology54(5), 1050–1058(2000).
   PubMed Web of Science ®Google Scholar
• Ferman TJ , SmithGE, BoeveBFet al.: DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging.Neurology62(2), 181–187(2004).
   PubMed Web of Science ®Google Scholar
• Del Ser T , HachinskiV, MerskeyH, Munoz DG: Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis. Assoc. Disord.15(1), 31–44(2001).
   PubMed Web of Science ®Google Scholar
• Merdes AR , HansenLA, JesteDVet al.: Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.Neurology60(10), 1586–1590(2003).
   PubMed Web of Science ®Google Scholar
• Ballard CG , JacobyR, Del Ser T et al.: Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am. J. Psychiatry161(5), 843–849(2004).
   PubMed Web of Science ®Google Scholar
• Tiraboschi P , SalmonDP, HansenLA, HofstetterRC, ThalLJ, Corey-BloomJ: What best differentiates Lewy body from Alzheimer‘s disease in early-stage dementia?Brain129(Pt 3), 729–735(2006).
   PubMed Web of Science ®Google Scholar
• Boeve BF , SilberMH, FermanTJ: REM sleep behavior disorder in Parkinson‘s disease and dementia with Lewy bodies.J. Geriatr. Psychiatry Neurol.17(3), 146–157(2004).
   PubMed Web of Science ®Google Scholar
• Aarsland D , PerryR, LarsenJPet al.: Neuroleptic sensitivity in Parkinson‘s disease and parkinsonian dementias.J. Clin. Psychiatry66(5), 633–637(2005).
   PubMed Web of Science ®Google Scholar
• O‘Brien JT , CollobyS, FenwickJet al.: Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.Arch. Neurol.61(6), 919–925(2004).
   PubMedGoogle Scholar
• Hu XS , OkamuraN, AraiHet al.: 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.Neurology55(10), 1575–1577(2000).
   PubMed Web of Science ®Google Scholar
• Orimo S , AminoT, ItohYet al.: Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.Acta Neuropathol.109(6), 583–588(2005).
   PubMed Web of Science ®Google Scholar
• Horimoto Y , MatsumotoM, AkatsuHet al.: Autonomic dysfunctions in dementia with Lewy bodies. J. Neurol.250(5), 530–533(2003).
   PubMed Web of Science ®Google Scholar
• Firbank MJ , CollobySJ, BurnDJ, McKeithIG, O‘BrienJT: Regional cerebral blood flow in Parkinson‘s disease with and without dementia.Neuroimage20(2), 1309–1319(2003).
   PubMed Web of Science ®Google Scholar
• Saiki S , HiroseG, SakaiKet al.: Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.J. Neurol. Sci.220(1–2), 105–111(2004).
   PubMed Web of Science ®Google Scholar
• Barber R , GholkarA, ScheltensP, BallardC, McKeithIG, O‘BrienJT: Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.Neurology52(6), 1153–1158(1999).
   PubMed Web of Science ®Google Scholar
• Walker MP , AyreGA, CummingsJLet al.: Quantifying fluctuation in dementia with Lewy bodies, Alzheimer‘s disease, and vascular dementia.Neurology54(8), 1616–1625(2000).
   PubMed Web of Science ®Google Scholar
• Boeve BF , SilberMH, FermanTJet al.: REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease.Neurology51(2), 363–370(1998).
   PubMed Web of Science ®Google Scholar
• Ferman TJ , BoeveBF, SmithGEet al.: Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations.J. Int. Neuropsychol. Soc.8(7), 907–914(2002).
   PubMed Web of Science ®Google Scholar
• Mori H : Pathological substrate of dementia in Parkinson‘s disease – its relation to DLB, DLBD.Parkinsonism Relat. Disord.11(Suppl. 1), S41–S45 (2005).
   PubMed Web of Science ®Google Scholar
• Jellinger KA : Pathological substrate of dementia in Parkinson‘s disease – its relation to DLB, DLBD.Parkinsonism Relat. Disord.12(2), 119–120(2005).
   PubMed Web of Science ®Google Scholar
• Aarsland D , PerryR, PerryE, Ballard, C: The neuropathology of dementia in Parkinson disease: a prospective community based study. First World Parkinson Congress, Washington, DC, USA, February 22–26 (2006).
   Google Scholar
• O‘Brien JT , MetcalfeS, SwannAet al.: Medial temporal lobe width on CT scanning in Alzheimer‘s disease: comparison with vascular dementia, depression and dementia with Lewy bodies.Dement. Geriatr. Cogn. Disord.11(2), 114–118(2000).
   PubMed Web of Science ®Google Scholar
• Colloby SJ , FenwickJD, WilliamsEDet al.: A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer‘s disease using statistical parametric mapping.Eur. J. Nucl. Med. Mol. Imaging29(5), 615–622(2002).
   PubMed Web of Science ®Google Scholar
• O‘Brien JT , FirbankMJ, MosimannUP, BurnDJ, McKeithIG: Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.Psychiatry Res.139(2), 79–88(2005).
   PubMed Web of Science ®Google Scholar
• Pasquier J , MichelBF, Brenot-RossiI, Hassan-SebbagN, SauvanR, GastautJL: Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.Eur. J. Nucl. Med. Mol. Imaging29(10), 1342–1348(2002).
   PubMed Web of Science ®Google Scholar
• Firbank MJ , BurnDJ, McKeithIG, O‘Brien JT: Longitudinal study of cerebral blood flow SPECT in Parkinson‘s disease with dementia, and dementia with Lewy bodies. Int. J. Geriatr. Psychiatry20(8), 776–782(2005).
   PubMed Web of Science ®Google Scholar
• Benamer TS , PattersonJ, GrossetDGet al.: Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.Mov. Disord.15(3), 503–510(2000).
   PubMed Web of Science ®Google Scholar
• O‘Brian J , McKeithI, AmesD, ChiuE: Chapter 9: Neuroimaging. In:Dementia with Lewy Bodies (1st Edition). Taylor & Francis, Abingdon, Oxfordshire, UK, 136 (2006).
   Google Scholar
• Walker Z , CostaDC, WalkerRWet al.: Differentiation of dementia with Lewy bodies from Alzheimer‘s disease using a dopaminergic presynaptic ligand.J. Neurol. Neurosurg. Psychiatr.73(2), 134–140(2002).
   PubMed Web of Science ®Google Scholar
• Colloby SJ , WilliamsED, BurnDJ, LloydJJ, McKeithIG, O‘BrienJT: Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson‘s disease with and without dementia assessed using 123I-FP-CIT SPECT.Eur. J. Nucl. Med. Mol. Imaging32(10), 1176–1185(2005).
   PubMed Web of Science ®Google Scholar
• Barber R , BallardC, McKeithIG, GholkarA, O‘BrienJT: MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia.Neurology54(6), 1304–1309(2000).
   PubMed Web of Science ®Google Scholar
• Cousins DA , BurtonEJ, BurnD, GholkarA, McKeithIG, O‘BrienJT: Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer‘s disease: an MRI study.Neurology61(9), 1191–1195(2003).
   PubMed Web of Science ®Google Scholar
• Hanyu H , TanakaY, ShimizuS, SakuraiH, IwamotoT, AbeK: Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer‘s disease.J. Neurol.252(4), 482–484(2005).
   PubMed Web of Science ®Google Scholar
• Tiraboschi R , HansenLA, AlfordMet al.: Cholinergic dysfunction in diseases with Lewy bodies.Neurology54, 407–411(2000).
   PubMed Web of Science ®Google Scholar
• Hentschel F , KreisM, DamianM, KrummB, FrolichL: The clinical utility of structural neuroimaging with MRI for diagnosis and differential diagnosis of dementia: a memory clinic study.Int. J. Geriatr. Psychiatry20(7), 645–650(2005).
   PubMed Web of Science ®Google Scholar
• Burton EJ , KarasG, PalingSMet al.: Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.Neuroimage17(2), 618–630(2002).
   PubMed Web of Science ®Google Scholar
• Burton EJ , McKeithIG, BurnDJ, WilliamsED, O‘BrienJT: Cerebral atrophy in Parkinson‘s disease with and without dementia: a comparison with Alzheimer‘s disease, dementia with Lewy bodies and controls.Brain127(Pt 4), 791–800(2004).
   PubMed Web of Science ®Google Scholar
• Aarsland D , BallardCG, HallidayG: Are Parkinson‘s disease with dementia and dementia with Lewy bodies the same entity?J. Geriatr. Psychiatry Neurol.17(3), 137–145(2004).
   PubMed Web of Science ®Google Scholar
• Ballmaier M , O‘BrienJT, BurtonEJet al.: Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer‘s disease using cortical pattern matching: diagnosis and gender effects.Neuroimage23(1), 325–335(2004).
   PubMed Web of Science ®Google Scholar
• Yoshita M : Differentiation of idiopathic Parkinson‘s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.J. Neurol. Sci.155(1), 60–67(1998).
   PubMed Web of Science ®Google Scholar
• Braune S , ReinhardtM, SchnitzerR, RiedelA, LuckingCH: Cardiac uptake of [123I]MIBG separates Parkinson‘s disease from multiple system atrophy.Neurology53(5), 1020–1025(1999).
   PubMed Web of Science ®Google Scholar
• Yoshita M , TakiJ, YamadaM: A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer‘s-type and dementia with Lewy bodies.J. Neurol. Neurosurg. Psychiatr.71(5), 583–588(2001).
   PubMed Web of Science ®Google Scholar
• Watanabe H , IedaT, KatayamaTet al.: Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer‘s disease.J. Neurol. Neurosurg. Psychiatr.70(6), 781–783(2001).
   PubMed Web of Science ®Google Scholar
• Suzuki M , KuritaA, HashimotoMet al.: Impaired myocardial (123)I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson‘s disease.J. Neurol. Sci.240(1–2), 15–19(2005).
   PubMed Web of Science ®Google Scholar
• Clark CM , XieS, ChittamsJet al.: Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?Arch. Neurol.60(12), 1696–1702(2003).
   PubMedGoogle Scholar
• Arai H , MorikawaY, HiguchiMet al.: Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.Biochem. Biophys. Res. Commun.236(2), 262–264(1997).
   PubMed Web of Science ®Google Scholar
• Parnetti L , LanariA, AmiciSet al.: CSF phosphorylated tau is a possible marker for discriminating Alzheimer‘s disease from dementia with Lewy bodies. Phospho-Tau International Study Group.Neurol. Sci.22(1), 77–78(2001).
   PubMed Web of Science ®Google Scholar
• Gomez-Tortosa E , GonzaloI, FanjulSet al.: Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.Arch. Neurol.60(9), 1218–1222(2003).
   PubMedGoogle Scholar
• Mollenhauer B , BiblM, TrenkwalderCet al.: Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer‘s disease. J. Neural Transm.112(7), 933–948(2005).
   PubMed Web of Science ®Google Scholar
• Bonner LT , TsuangDW, CherrierMMet al.: Familial dementia with Lewy bodies with an atypical clinical presentation. J. Geriatr. Psychiatry Neurol.16(1), 59–64(2003).
   PubMed Web of Science ®Google Scholar
• Brett FM , HensonCG, StauntonH: Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology.Arch. Neurol.59(3), 464–467(2002).
   PubMedGoogle Scholar
• Sleegers K , RoksG, TheunsJet al.: Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.Brain127(Pt 7), 1641–1649(2004).
   PubMed Web of Science ®Google Scholar
• Galvin JE , LeeSL, PerryA, HavliogluN, McKeelDW Jr, Morris JC: Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. Neurology59(7), 1079–1082(2002).
   PubMed Web of Science ®Google Scholar
• Tsuang DW , DalanAM, EugenioCJet al.: Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families.Arch. Neurol.59(10), 1622–1630(2002).
   PubMedGoogle Scholar
• Zarranz JJ , AlegreJ, Gomez-EstebanJCet al.: The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol.55(2), 164–173(2004).
   PubMed Web of Science ®Google Scholar
• Ibanez P , BonnetAM, DebargesBet al.: Causal relation between alpha-synuclein gene duplication and familial Parkinson‘s disease.Lancet364(9440), 1169–1171(2004).
   PubMed Web of Science ®Google Scholar
• Singleton AB , FarrerM, JohnsonJet al.: Alpha-synuclein locus triplication causes Parkinson‘s disease.Science302(5646), 841 (2003).
   PubMed Web of Science ®Google Scholar
• Ohtake H , LimprasertP, FanYet al.: Beta-synuclein gene alterations in dementia with Lewy bodies.Neurology63(5), 805–811(2004).
   PubMed Web of Science ®Google Scholar
• Singleton AB , WhartonA, O‘BrienKKet al.: Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement. Geriatr. Cogn. Disord.14(4), 167–175(2002).
   PubMed Web of Science ®Google Scholar
• Tsuang DW , WilsonRK, LopezOLet al.: Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.Neurology64(3), 509–513(2005).
   PubMed Web of Science ®Google Scholar
• Nielsen AS , RavidR, KamphorstW, JorgensenOS: Apolipoprotein E epsilon 4 in an autopsy series of various dementing disorders.J. Alzheimers Dis.5(2), 119–125(2003).
   PubMed Web of Science ®Google Scholar
• Barber R , PanikkarA, McKeithIG: Dementia with Lewy bodies: diagnosis and management.Int. J. Geriatr. Psychiatry16(Suppl. 1), S12–S18 (2001).
   PubMed Web of Science ®Google Scholar
• McKeith I , Del Ser T, Spano P et al.: Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet356(9247), 2031–2036(2000).
   PubMed Web of Science ®Google Scholar
• Aarsland D , MosimannUP, McKeithIG: Role of cholinesterase inhibitors in Parkinson‘s disease and dementia with Lewy bodies.J. Geriatr. Psychiatry Neurol.17(3), 164–171(2004).
   PubMed Web of Science ®Google Scholar
• Wesnes KA , McKeithIG, FerraraRet al.: Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.Dement. Geriatr. Cogn. Disord.13(3), 183–192(2002).
   PubMed Web of Science ®Google Scholar
• McKeith IG , WesnesKA, PerryE, Ferrara R: Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dement. Geriatr. Cogn. Disord.18(1), 94–100(2004).
   PubMed Web of Science ®Google Scholar
• Bullock R , TouchonJ, BergmanHet al.: Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer‘s disease over a 2-year period.Curr. Med. Res. Opin.21(8), 1317–1327(2005).
   PubMed Web of Science ®Google Scholar
• Levy R , EaggerS, GriffithsMet al.: Lewy bodies and response to tacrine in Alzheimer‘s disease.Lancet343(8890), 176 (1994).
   PubMed Web of Science ®Google Scholar
• Molloy S , McKeithIG, O‘BrienJT, Burn DJ: The role of levodopa in the management of dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatr.76(9), 1200–1203(2005).
   PubMed Web of Science ®Google Scholar
• Bonelli SB , RansmayrG, SteffelbauerM, LukasT, LamplC, DeiblM: L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia.Neurology63(2), 376–378(2004).
   PubMed Web of Science ®Google Scholar
• McKeith I , FairbairnA, PerryR, ThompsonP, PerryE: Neuroleptic sensitivity in patients with senile dementia of Lewy body type.Br. Med. J.305(6855), 673–678(1992).
   PubMed Web of Science ®Google Scholar
• Ballard C , GraceJ, McKeithI, HolmesC: Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer‘s disease.Lancet351(9108), 1032–1033(1998).
   PubMed Web of Science ®Google Scholar
• Mulsant BH , LehmanM, GharabawiGet al.: Differential anticholinergic activity of antipsychotic medications. 5th Annual Meeting of the International College of Geriatric Psychoneuropharmacology, Pittsburgh, PA, USA (2005).
   Google Scholar
• Walker Z , GraceJ, OvershotRet al.: Olanzapine in dementia with Lewy bodies: a clinical study.Int. J. Geriatr. Psychiatry14(6), 459–466(1999).
   PubMed Web of Science ®Google Scholar
• Cummings JL , StreetJ, MastermanD, ClarkWS: Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.Dement. Geriatr. Cogn. Disord.13(2), 67–73(2002).
   PubMed Web of Science ®Google Scholar
• Fernandez HH , TrieschmannME, BurkeMA, FriedmanJH: Quetiapine for psychosis in Parkinson‘s disease versus dementia with Lewy bodies.J. Clin. Psychiatry63(6), 513–515(2002).
   PubMed Web of Science ®Google Scholar
• Takahashi H , YoshidaK, SugitaT, HiguchiH, ShimizuT: Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.Prog. Neuropsychopharmacol. Biol. Psychiatry27(3), 549–553(2003).
   PubMed Web of Science ®Google Scholar
• Aarsland D , LarsenJP, KarlsenK, LimNG, TandbergE: Mental symptoms in Parkinson‘s disease are important contributors to caregiver distress.Int. J. Geriatr. Psychiatry14(10), 866–874(1999).
   PubMed Web of Science ®Google Scholar
• Thomas AJ , BurnDJ, RowanENet al.: A comparison of the efficacy of donepezil in Parkinson‘s disease with dementia and dementia with Lewy bodies.Int. J. Geriatr. Psychiatry20(10), 938–944(2005).
   PubMed Web of Science ®Google Scholar

Website

• The Lewy Body Dementia Association www.lewybodydementia.org.
   Google Scholar